Archived Newsletters
-
10.14.21 -- Enhancing Bioavailability For Early Development Phase Molecules
10/14/2021
10/14/21 Outsourced Pharma Newsletter
-
10.13.21 -- Tackling The Challenges Of Biologics Development And Manufacturing
10/13/2021
10/13/21 Outsourced Pharma Newsletter
-
10.13.21 -- Should You Build Where You Buy? A Rarely Discussed Model For Biopharma
10/13/2021
10/13/21 Outsourced Pharma Newsletter
-
10.12.21 -- Building More Resilient API Supply Chains
10/12/2021
10/12/21 Outsourced Pharma Newsletter
-
10.12.21 -- How Well Are CMOs/CDMOs Meeting Sponsor Expectations?
10/12/2021
10/12/21 Outsourced Pharma Newsletter
-
10.11.21 -- Innovation And Industrialization For Cell & Gene Therapies
10/11/2021
10/11/21 Outsourced Pharma Newsletter
-
10.11.21 -- CEOs And The Complexities Of Outsourcing
10/11/2021
10/11/21 Outsourced Pharma Newsletter
-
10.07.21 -- Accelerating Biologics Development And Economizing Distribution
10/7/2021
10/07/21 Outsourced Pharma Newsletter
-
10.07.21 -- 5 Strategies For Your Future Success
10/7/2021
10/07/21 Outsourced Pharma Newsletter
-
10.06.21 -- Strategies To Optimize Cell And Gene Therapy Manufacturing
10/6/2021
10/06/21 Outsourced Pharma Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more